Brokerages Set Bath & Body Works, Inc. (NYSE:BBWI) Target Price at $22.00

Bath & Body Works, Inc. (NYSE:BBWI) has been given an average rating of “Hold” by the eighteen research firms that are covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, fourteen have given a hold rating and three have issued a buy rating on the company. The average 12 month target price among analysts that have covered the stock in the last year is $22.00.

Several brokerages recently issued reports on BBWI. Weiss Ratings raised shares of Bath & Body Works from a “sell (d+)” rating to a “hold (c-)” rating in a report on Thursday, July 9th. UBS Group lowered their price target on shares of Bath & Body Works from $22.00 to $19.00 and set a “neutral” rating on the stock in a report on Wednesday, May 20th. Piper Sandler assumed coverage on Bath & Body Works in a research report on Friday, May 15th. They set a “neutral” rating and a $20.00 price target on the stock. Morgan Stanley reiterated an “equal weight” rating and set a $22.00 price objective on shares of Bath & Body Works in a research note on Monday, July 6th. Finally, TD Cowen boosted their price objective on Bath & Body Works from $20.00 to $25.00 and gave the company a “buy” rating in a report on Thursday, May 28th.

Bath & Body Works Trading Down 3.8%

Shares of NYSE:BBWI opened at $19.29 on Friday. Bath & Body Works has a twelve month low of $14.27 and a twelve month high of $32.95. The company’s 50 day moving average is $19.76 and its 200 day moving average is $20.44. The company has a market cap of $3.89 billion, a PE ratio of 5.42, a price-to-earnings-growth ratio of 1.98 and a beta of 1.38.

Bath & Body Works (NYSE:BBWI) last announced its quarterly earnings data on Wednesday, May 27th. The company reported $0.32 EPS for the quarter, beating the consensus estimate of $0.29 by $0.03. The business had revenue of $1.38 billion during the quarter, compared to analysts’ expectations of $1.36 billion. Bath & Body Works had a net margin of 10.03% and a negative return on equity of 45.34%. The business’s quarterly revenue was down 3.2% compared to the same quarter last year. During the same period in the previous year, the business posted $0.49 EPS. Bath & Body Works has set its Q2 2026 guidance at 0.300-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. Equities research analysts predict that Bath & Body Works will post 2.63 earnings per share for the current fiscal year.

Bath & Body Works Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, June 19th. Investors of record on Friday, June 5th were given a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a yield of 4.1%. The ex-dividend date was Friday, June 5th. Bath & Body Works’s dividend payout ratio (DPR) is currently 22.47%.

Institutional Inflows and Outflows

A number of large investors have recently bought and sold shares of BBWI. AQR Capital Management LLC grew its stake in shares of Bath & Body Works by 132.5% during the 4th quarter. AQR Capital Management LLC now owns 11,445,928 shares of the company’s stock worth $229,834,000 after purchasing an additional 6,523,960 shares during the period. Alliancebernstein L.P. lifted its stake in shares of Bath & Body Works by 5.8% in the 2nd quarter. Alliancebernstein L.P. now owns 5,737,796 shares of the company’s stock valued at $171,904,000 after purchasing an additional 315,738 shares during the period. Geode Capital Management LLC lifted its stake in shares of Bath & Body Works by 2.9% in the 4th quarter. Geode Capital Management LLC now owns 3,960,475 shares of the company’s stock valued at $79,542,000 after purchasing an additional 110,602 shares during the period. Bank of America Corp DE boosted its holdings in Bath & Body Works by 86.9% during the third quarter. Bank of America Corp DE now owns 3,399,390 shares of the company’s stock worth $87,568,000 after buying an additional 1,580,176 shares in the last quarter. Finally, Vaughan Nelson Investment Management L.P. boosted its holdings in Bath & Body Works by 33.8% during the first quarter. Vaughan Nelson Investment Management L.P. now owns 2,852,040 shares of the company’s stock worth $53,248,000 after buying an additional 719,795 shares in the last quarter. 95.14% of the stock is owned by institutional investors and hedge funds.

About Bath & Body Works

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.